MA
PROF

MCF Advisors’s Profound Medical PROF Stock Holding History

MCF Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Hold
2,000
– – ﹤0.01% 911
2025
Q4 		$15.7K Buy
+2,000
New +$12.9K ﹤0.01% 734

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

MCF Advisors's PROF Position: Q1 2026 in Review

MCF Advisors held its Profound Medical (PROF) position steady in Q1 2026 at 2,000 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #911.

MCF Advisors first reported a position in PROF in Q4 2025 and has held it in 2 quarters since. The position peaked at $15.7K in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • MCF Advisors held 2,000 shares of Profound Medical worth $13K as of Q1 2026.
  • MCF Advisors left its Profound Medical share count unchanged in Q1 2026.
  • Profound Medical made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #911 holding.
  • MCF Advisors first reported a position in Profound Medical in Q4 2025 and has held it in 2 quarters since.
  • MCF Advisors's Profound Medical position peaked at $15.7K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.